Assess
Review current program state, constraints, interdependencies, and the decisions most likely to shape near-term progress. Identify where structure is missing and where execution risk is highest.
Built for emerging biotech, pharma development teams, and medical device companies that need experienced program leadership — without the overhead of a full-time hire.
Emerging Biotech·Pharma Operations·Medical Device & 510(k)/PMA
NanoCoeur brings experienced program leadership to the moments where structure, alignment, and execution discipline make the biggest difference — across biotech, pharma, and medical device development.
Fifteen-plus years of hands-on program experience across the organizations that set the standard in life sciences — medical device development with Boston Scientific, Medtronic, Johnson & Johnson, and Smith & Nephew; diagnostics and hemostasis programs with Abbott, Siemens, and Haemonetics; clinical and program execution across global pharmaceutical and biotechnology organizations; and operational delivery with partners including LabCorp, ICON, and Syneos Health.
That's the foundation NanoCoeur brings to your programs today — the same agile discipline, the same intolerance for imprecision, applied across the full development lifecycle, from early R&D through commercialization.
Review current program state, constraints, interdependencies, and the decisions most likely to shape near-term progress. Identify where structure is missing and where execution risk is highest.
Clarify priorities, ownership, governance, and the execution path for stronger readiness and fewer cross-functional blind spots. Resolve the interdependencies that slow programs before they become crises.
Provide hands-on program leadership and execution support where discipline, visibility, and momentum are needed most — from milestone planning through regulatory submission and commercial readiness.
Engagements range from targeted strategic support around a single milestone to hands-on leadership across planning, governance, and execution — scoped to what your program actually needs.
Focused perspectives on the operating challenges that matter most — also shared on LinkedIn.
July 6, 2026
June 25, 2026
June 22, 2026
NanoCoeur supports biotech, pharma, and medical device teams navigating complex milestones across the full development lifecycle. For consulting inquiries, introductions, or referred opportunities, use the form to get in touch.
Share a few details and we'll follow up to discuss fit.